Quality Assurance for Antimicrobial Susceptibility Testing of Neisseria gonorrhoeae in Canada, 2003 to 2012.
Data from the Canadian National Gonococcal Antimicrobial Susceptibility Comparison Program, including results from 25 proficiency panels distributed between 2003 and 2012, were analyzed. The average MIC agreement between the participating laboratories ranged from 85.6% to 98.8% over the 10-year period, with the interpretation agreement ranging from 85.7% to 98.1%.
Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Pam
P
Sawatzky
Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada.
Gary
G
Liu
University of Saskatchewan, Saskatoon, Saskatchewan, Canada.
Jo-Anne R
JA
Dillon
Public Health Ontario Laboratories, Toronto, Ontario, Canada.
Vanessa
V
Allen
Laboratoire de Santé Publique du Québec, Ste-Anne-de-Bellevue, Québec, Canada.
Brigitte
B
Lefebvre
British Columbia Public Health Microbiology and Reference Laboratory, Vancouver, British Columbia, Canada.
Linda
L
Hoang
Provincial Laboratory for Public Health, Edmonton, Alberta, Canada.
Greg
G
Tyrrell
Cadham Provincial Laboratory, Winnipeg, Manitoba, Canada.
Paul
P
Van Caeseele
Saskatchewan Disease Control Laboratory, Regina, Saskatchewan, Canada.
Paul
P
Levett
Bacteriology and Enteric Diseases Program, National Microbiology Laboratory, Public Health Agency of Canada, Winnipeg, Manitoba, Canada irene.martin@phac-aspc.gc.ca.
Irene
I
Martin
D000900:Anti-Bacterial Agents / Q000494:pharmacology*; D002170:Canada; D024881:Drug Resistance, Bacterial; D006069:Gonorrhea / Q000188:drug therapy; D008826:Microbial Sensitivity Tests / Q000379:methods*; D009344:Neisseria gonorrhoeae / Q000187:drug effects*; D011785:Quality Assurance, Health Care
D000900:Anti-Bacterial Agents